Back to List View Graph View

Caelyx

Caelyx is a pegylated liposomal formulation of the anthracycline cytotoxic drug doxorubicin, administered intravenously to treat cancer.

Where the papers sit

11 papers from the last 6 months study caelyx directly · updated from PubMed 11 Nov 2026

  • Doxorubicin Delivery and Combination Therapy

    Doxorubicin therapy is moving toward engineered carriers and combination regimens that improve penetration while limiting systemic toxicity. FAP-responsive nanoparticles remodel fibrotic stroma in hepatocellular carcinoma, and carbon dots or liposomes provide controlled delivery. Photothermal treatment and nab-paclitaxel are recurring partners, with evidence spanning preclinical models and a phase II study in adenoid cystic carcinoma. Manufacturing scale-up and clinical validation remain open challenges.

    5 papers · 45.5%

  • Multifunctional Nanocarrier Drug Delivery

    Multifunctional nanocarriers are being developed to improve doxorubicin delivery, tumor penetration and treatment selectivity. Aptamer-functionalized liposomes, chitosan micelles and injectable hydrogels combine targeting with controlled or self-amplified release. Galectin-3 targeting provides a route to tumor-associated molecular recognition, while oral formulations address absorption limits. Photochemotherapy and theranostic designs broaden delivery beyond conventional systemic dosing.

    4 papers · 36.4%

  • Sialic Acid-Targeted Nanotherapy

    Sialic acid overexpression is being exploited to concentrate nanotherapeutics in cancer cells while combining cytotoxic and immune-modulating effects. Polymerized polyphenol-decorated cationic complexes target breast cancer cells, whereas hybrid nanogels deliver doxorubicin and zinc to sialic acid-rich lung cancers. Hyaluronic acid, alginate and N-acetyl-β-neuraminic acid recur as components of the targeting or carrier chemistry. Reported progress centers on selective uptake and lower inhibitory concentrations, but broader validation remains needed.

    2 papers · 18.2%

Papers

The 11 papers from the last 6 months that study caelyx directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Doxorubicin Delivery and Combination Therapy (5)
  1. FAP-α-Responsive Size-Transformable Lipid Nanoparticles for Stromal Remodeling and Enhanced Drug Penetration in Fibrotic Hepatocellular Carcinoma. ACS applied materials & interfaces · 22 Jun 2026 PMID 42328782
  2. Engineering functionalized carbon dots as biocompatible nanocarriers for controlled doxorubicin delivery in cancer therapy. Journal of materials chemistry. B · 16 Jun 2026 PMID 42300585
  3. Liposomal doxorubicin plus nab-paclitaxel with/without chemoradiotherapy in head and neck adenoid cystic carcinoma: single-arm phase II study. Signal transduction and targeted therapy · 12 Jun 2026 PMID 42285940
  4. Microfluidic-active loading integration enables rapid two-step manufacturing of antibiotic-loaded liposomes with intravesicular drug nanocrystallization. International journal of pharmaceutics · 10 Jun 2026 PMID 42269791
  5. Enhanced Therapeutic Efficacy of Combined Photothermal Therapy and Doxorubicin Chemotherapy in Anaplastic Thyroid Carcinoma: An Innovative Treatment Approach. Molecular pharmaceutics · 4 Jun 2026 PMID 42243048
Multifunctional Nanocarrier Drug Delivery (4)
  1. Engineering Coil-Coiled Domains for the Design of Modular Theranostic Agents: Galectin-3 as a Targeting Moiety. Biomacromolecules · 27 Jun 2026 PMID 42363882
  2. Photocage Prodrug Coupled with Injectable Hydrogel for Self-Amplified Photochemotherapy. Journal of medicinal chemistry · 26 Jun 2026 PMID 42358122
  3. Aptamer-Functionalized Liposome Delivery System Based on Multifunctional Microreactor Design. ACS applied materials & interfaces · 24 Jun 2026 PMID 42339546
  4. Multi-functional purine nucleoside-modified chitosan polymer micelles for improving the oral absorption of doxorubicin based on nucleoside transporter mediation. International journal of pharmaceutics · 14 Jun 2026 PMID 42289209
Sialic Acid-Targeted Nanotherapy (2)
  1. Targeted hybrid nanogels for sialic acid-overexpressing lung cancers: DNA-mediated chelation of doxorubicin and adsorption of zinc ions. International journal of biological macromolecules · 11 Jun 2026 PMID 42276469
  2. Polymerized Polyphenol-Decorated Cationic Hydroxyethylcellulose Nanocomplexes for Enhanced Breast Cancer Cell Killing Effects. Biomacromolecules · 28 May 2026 PMID 42210019

By study type

Clinical trials (1)
  1. Liposomal doxorubicin plus nab-paclitaxel with/without chemoradiotherapy in head and neck adenoid cystic carcinoma: single-arm phase II study. Signal transduction and targeted therapy · 12 Jun 2026 PMID 42285940
Preclinical: animal, cell and lab studies (10)
  1. Engineering Coil-Coiled Domains for the Design of Modular Theranostic Agents: Galectin-3 as a Targeting Moiety. Biomacromolecules · 27 Jun 2026 PMID 42363882
  2. Photocage Prodrug Coupled with Injectable Hydrogel for Self-Amplified Photochemotherapy. Journal of medicinal chemistry · 26 Jun 2026 PMID 42358122
  3. Aptamer-Functionalized Liposome Delivery System Based on Multifunctional Microreactor Design. ACS applied materials & interfaces · 24 Jun 2026 PMID 42339546
  4. FAP-α-Responsive Size-Transformable Lipid Nanoparticles for Stromal Remodeling and Enhanced Drug Penetration in Fibrotic Hepatocellular Carcinoma. ACS applied materials & interfaces · 22 Jun 2026 PMID 42328782
  5. Engineering functionalized carbon dots as biocompatible nanocarriers for controlled doxorubicin delivery in cancer therapy. Journal of materials chemistry. B · 16 Jun 2026 PMID 42300585
  6. Multi-functional purine nucleoside-modified chitosan polymer micelles for improving the oral absorption of doxorubicin based on nucleoside transporter mediation. International journal of pharmaceutics · 14 Jun 2026 PMID 42289209
  7. Targeted hybrid nanogels for sialic acid-overexpressing lung cancers: DNA-mediated chelation of doxorubicin and adsorption of zinc ions. International journal of biological macromolecules · 11 Jun 2026 PMID 42276469
  8. Microfluidic-active loading integration enables rapid two-step manufacturing of antibiotic-loaded liposomes with intravesicular drug nanocrystallization. International journal of pharmaceutics · 10 Jun 2026 PMID 42269791
  9. Enhanced Therapeutic Efficacy of Combined Photothermal Therapy and Doxorubicin Chemotherapy in Anaplastic Thyroid Carcinoma: An Innovative Treatment Approach. Molecular pharmaceutics · 4 Jun 2026 PMID 42243048
  10. Polymerized Polyphenol-Decorated Cationic Hydroxyethylcellulose Nanocomplexes for Enhanced Breast Cancer Cell Killing Effects. Biomacromolecules · 28 May 2026 PMID 42210019